Anthera Pharmaceuticals to price public offering of common shares

Bookrunners Piper Jaffray and Leerink Swann are assisting with sale

By Devika Patel

Knoxville, Tenn., July 18 - Anthera Pharmaceuticals, Inc. plans to price a public offering of common stock with a 30-day greenshoe option, according to a preliminary prospectus supplement filed Wednesday with the Securities and Exchange Commission.

Piper Jaffray & Co. and Leerink Swann LLC are the joint bookrunning managers.

Proceeds will be used for general corporate purposes.

Anthera, based in Hayward, Calif., is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.